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ARDS and Cerebral Infarction Complicating Mycoplasma
Pneumonia in Sickle Cell Traitt
Mark I. Pensler, MD* and Jan R. Radke, MD*

A patient with Down's
syndrome
and sickle cell
trait
developed
the adult respiratory
distress syndrome
and
cerebral
infarction
during
infection
with
Mycoplasma
pneumoniae.
The slow recovery of pulmonary
function
was unrelated to antimicrobial
therapy. Sickle cell trait may

be a nsk factor for severe M. pneumoniae
infection.
The
possible underlying
mechanism
for this relationship
is explored, and the relationship
between sickle cell trait, cold
agglutinins,
and the cerebral infarction
is discussed.

N 4 y c o p l a s m a pneumoniae usually causes upper respiratory tract symptoms or a mild pneumonia (1), although
severe complications (2,3) are occasionally seen. Unusually severe cases have been reported previously in both
sickle cell (4) and sickle cell-hemoglobin C disease (5,6).
This report describes the clinical course of a patient with
sickle cell trait who developed rising complement fixation
titers to M. pneumoniae.

and the Babinski response was extensor on the right. The remainder of the examination was unremarkable.
A chest radiograph (Fig. 1) revealed diffuse infiltrates in both lung
fields. The hemoglobin was 8.3 gm% with no sickle forms noted
on peripheral smear. On room air the arterial blood oxygen
tension (PaOj) was 32 mm Hg, arterial blood carbon dioxide
(PaCOj) was40 mm Hg, and pH 7.32. Cram stain ofthe yellowish
sputum revealed numerous polymorphonuclear leukocytes but
no organisms. Cerebrospinal fluid was clear, colorless, and without cells or organisms.
Because of the progressive respiratoryfailure, the patient required
ventilatory support. Pulmonary and femoral arterial catheters
were inserted. Positive end expiratory pressure (PEEP) of 10 cm of
water was added to help decrease inspired oxygen concentration
and venous admixture. The patient received erythromycin (1 gm
every 6 hours), nafcillin, and gentamycin, although only the
erythromycin was continued after sputum and blood cultures
were reported to be negative. A neurology consultant agreed with
thediagnosisof a large infarct in the disttibution o f t h e left middle
cerebral artery.

Case Report
A 21-year-old black man with Down's syndrome was admitted to
Henry Ford Hospital in severe respiratory distress with a one-week
history of sore throat, sneezing, and increased respiratory secretions. An older brother had similar symptoms. After admission, the
patient developed anorexia, fever, headache, and shortness of
breath followed by sudden weakness of his right side. He had no
known cardiac disease.
Physical examination revealed an agitated patient in marked
respiratory distress. His temperature was 39.5°C, blood pressure
100/80 mm Hg, and pulse 104/minute and regular. Typical
stigmata of Down's syndrome were present. The tympanic membranes and the carotid pulses were normal; no bruits were noted.
Inspiratory crackles were heard over both lower lung fields anteriorly and posteriorly. There was conjugate deviation of the eyes
to the left. His right arm and leg exhibited flaccid hemiparesis.

The cold agglutinin titer was 1:2,048 on day 1 and 1:131,072 on
day 11. Complement fixation level for M. pneumoniae was 1:64
on day 1 and 1:512 on day 11. Hemoglobin electrophoresis
revealed hemoglobin A at 65.1%, hemoglobin A2 at 2.6%, and
hemoglobin S at 32.3%. The patient was anergic. Serum protein
and Immunoelectrophoresis showed no immunoglobin deficiency. Intracerebral hemorrhage, abscess, and subdural hematoma were ruled out because computerized tomography of the
brain revealed no abnormality on day 1. An echocardiogram was
normal.
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The patient's respiratory status stabilized, and he was switched to
continuous positive a'\rway pressure (CPAP) on day 6. Progress
was slow, and CPAP was required until day 18. Finally on day 30
the patient was discharged with an expressive aphasia, complete
paralysis o f t h e right arm, and minimal weakness of the right leg.
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ship is unclear, although complicating pulmonary infarction has been suggested. In situ pulmonary thrombosis has
been diagnosed in a patient with sickle cell trait (9), but
whether in situ pulmonary thrombosis occurred in our
patient and perpetuated the ARDS cannot be proven.
The second feature of interest is the development of cerebral infarction in a patient with sickle cell trait Sears (8)
states that sickle cell trait is a benign disese in which only
rare kidney and splenic abnormalities are proven complications. Although he cited case reports of large vessel
occlusions involving cerebral and pulmonary arteries, he
did not believe an association had been clearly established.
Also, there have been no documented cases of hemiplegia
in M. pneumoniae infection (3). Therefore, the etiology of
the cerebral thrombosis in our patient is speculative; however, two explanations seem feasible.
Sickle cell trait erythrocytes have been shown to sickle in
vitro when conditions of acidosis and hypoxia exist (14,
15). It is possible that the profound hypoxemia and acidosis
secondary to the ARDS induced sickling, with resulting
thrombosis in the cerebral circulation. A second possible
mechanism involves cold agglutinins which cause a disease of skin capillaries of exposed extremities, resulting in
acrocyanosis and Raynaud's phenomenon (13). These
alone, however, would not cause large vessel thrombosis.
Burchmore (16) documented a case of tibial artery occlusion in a patient with sickle cell-hemoglobin C disease and
high levels of cold agglutinins. Thus, some interaction
between sickling and cold agglutinins is possible.

Fig.1
chest radiograph on admission revealed diffuse infiltrates.

Discussion
Frequent symptoms in the usual benign case of Mycoplasma pneumoniae infection include fever, cough,
headache, chills, and malaise. Nasal symptoms and sore
throat are seen in approximately halfthe cases (1). When
the lung becomes involved, the radiograph typically reveals unilateral broncho-pneumonia ofthe lower lobes (3).
Patients who are adequately treated improve rapidly with
defervescence in one to three days. Our patient presented
in this typical fashion, with upper respiratory tract symptoms and a recent family history of a similar illness. However, the onset of the pneumonia was extremely rapid and
fulminant, and he developed the adult respiratory distress
syndrome (ARDS), which is a rarely reported complication
of M. pneumoniae infection.

Finally, it is doubtful that Down's syndrome had anything
to do with the severity of our case, since Down's patients
have only mild immunologic deficiencies (10, 11). In fact,
there is some indication that immunodeficient states actually lessen the degree of pneumonia in patients with M.
pneumoniae infection (6, 12). We speculate that the unusually prolonged and severe course of M. pneumoniae
infection in this patient, with complications of ARDS and
cerebral thrombosis, are due to the synergistic effects of
hypoxemia, acidosis, high cold agglutinins, and sickle cell
trait.

Fishman et al (2) described two cases of ARDS caused by
M. pneumoniae, but the diagnosis was made retrospectively, and no specific therapy was given. Jastremski (7)
reported three cases of ARDS in M. pneumoniae infection.
One patient died within 24 hours, and the other two
needed seven to ten days of PEEP before they recovered.
The prolonged requirement for PEEP/CPAP (18 days) in our
patient suggests that early administration of erythromycin
(started on day 1) does not alter the clinical course of this
complication.
M. pneumoniae has been reported to cause unusually
severe infections in both sickle cell (4) and sickle cellhemoglobin C (5, 6) disease. The reason for this relation-
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